Results 271 to 280 of about 425,528 (280)
Some of the next articles are maybe not open access.

Renal cell carcinoma

Current Opinion in Oncology, 1998
Renal cell carcinoma (RCC) continues to be a frustrating tumor for clinicians to manage and treat. Progress has been made in the identification of risk factors, particularly dietary risk factors. An increased risk has been seen with frequent consumption of fried meat and poultry.
P A, Godley, M A, Escobar
openaire   +2 more sources

Renal cell carcinoma

Current Opinion in Oncology, 2001
Several renal cell carcinoma (RCC) prognostic factors show promise, including K1-67, p53/mdm-2, and vascular endothelial growth factor. The combination of increased incidence of RCC and diagnosis during earlier stages has generated interest in local therapeutic options.
P A, Godley, M, Taylor
openaire   +2 more sources

Renal Cell Carcinoma

Journal of Urology, 1988
There are 12 000–17 000 new cases of renal cell carcinoma in the United States per year. Renal cell carcinoma is responsible for 7000 to 9000 deaths annually. Approximately 56% of the cases are localized, 14% are locally advanced, and 30% of patients present with metastatic disease.
openaire   +3 more sources

Renal cell carcinoma

Current Opinion in Oncology, 1999
In addition to the known risk factors for renal cell carcinoma, hypertension, obesity, and tobacco use, a diet high in consumption of fried or sautéed meat and the frequent consumption of poultry may increase the risk for renal cell carcinoma. A diet high in consumption of fruits and vegetables appears to have a protective effect. Molecular markers, in
P A, Godley, T E, Stinchcombe
openaire   +2 more sources

Renal cell carcinoma

Current Opinion in Oncology, 2007
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell   +2 more
openaire   +2 more sources

Renal cell carcinoma

Current Opinion in Oncology, 2003
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire   +2 more sources

Renal cell carcinoma

The Lancet
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young   +7 more
openaire   +2 more sources

Radiotherapy for renal-cell carcinoma

The Lancet Oncology, 2014
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If given in a few (even single) fractions, but at a high fraction dose, stereotactic body radiotherapy becomes increasingly important in the management of renal-cell carcinoma, both in primary settings and in treatment of oligometastatic disease.
De Meerleer, Gert   +11 more
openaire   +3 more sources

Renal-Cell Carcinoma [PDF]

open access: possibleNew England Journal of Medicine, 1996
David M. Nanus   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy